Orthostatic Hypotension Is Associated With Cognitive Decline in Parkinson Disease.
Katherine Longardner, Ece Bayram, Irene Litvan
https://pubmed.ncbi.nlm.nih.gov/32982926/Actively Recruiting
Led by University of California, San Diego · Updated on 2026-08-07
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
Parkinsons disease PD is a common neurodegenerative disorder that affects movement and thinking. This research aims to understand how blood pressure BP, especially low BP when standing called orthostatic hypotension OH, affects brain function and thinking in people with PD. The study compares people with PD who have OH to those who do not, using innovative wearable technology to continuously measure BP and brain blood flow during cognitive tests. Participants will undergo cognitive testing while lying down and while upright on a tilt table. The study uses a continuous non-invasive BP monitor worn on the wrist and a functional near-infrared spectroscopy fNIRS cap to measure brain blood flow. Testing sessions alternate positions and are randomized in order. Baseline and screening visits include multiple assessments, including a tilt table test to confirm OH, questionnaires, physical exams, and cognitive evaluations. Participants will be monitored closely during cognitive tasks that last about 1 hour and 20 minutes total. BP and brain oxygenation changes are recorded continuously and synchronized with cognitive testing. The study measures thinking ability using the Delis-Kaplan Executive Function System Verbal Fluency Test and tracks changes in brain oxygen levels. The total participation involves a screening visit and a baseline study visit, each lasting about 3 hours.
CONDITIONS
Blood Pressure Effects on Cognition and Brain Blood Flow in PD
K
Katherine Longardner, MD
M
Michael Skipworth, BS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, San Diego
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Supine & Upright Cognitive Testing (Randomized Order) | Standard Resting Cognitive Assessment |
|---|---|---|
| What is it? | A randomized diagnostic protocol where cognitive testing and measures of brain blood flow are completed by participants with Parkinson disease in both supine and upright (tilt-table) positions, with the order of testing randomized. | Routine clinical cognitive assessment and blood pressure measurement in people with Parkinson disease, generally performed at rest (supine or seated) without controlled orthostatic challenge. |
| Role in trial | Main diagnostic testing approach evaluated; all enrolled participants complete cognitive and cerebral blood flow assessments in both positions to compare effects of posture on cognition. | Serves as the established clinical assessment, providing context for interpreting the impact of orthostatic stress on cognitive performance. |
| Primary use | To determine how orthostatic hypotension (drop in blood pressure when standing) changes cognitive performance and brain blood oxygen levels in Parkinson disease by directly comparing supine and upright states. | To evaluate cognitive function and detect cognitive impairment in Parkinson disease patients during routine clinical visits without orthostatic challenge. |
| How is it performed? | Participants complete validated cognitive tests and have brain blood flow measured using functional near-infrared spectroscopy (fNIRS) in both supine and upright positions on a tilt-table, with the order randomized. | Clinical cognitive testing and routine non-invasive blood pressure checks are conducted in the office or clinic while the patient is seated or lying down, usually without position-induced blood pressure variation. Advanced brain blood flow imaging is not routinely included. |
| Evidence status | Currently under investigation; evidence from small studies indicates that upright posture may worsen cognitive function in Parkinson disease with orthostatic hypotension, but broader clinical effectiveness across settings has not yet been established. | Widely established and used for identifying baseline cognitive impairment, but does not detect posture-induced cognitive changes. Standard assessments may miss transient declines that occur during orthostatic stress. |
| Important limitations | Tilt-table and upright cognitive assessments require specialized equipment and trained personnel, may not reflect typical clinic conditions, and could be influenced by patients' physical ability and comfort with position changes. The findings may not generalize to all Parkinson disease patients. | Routine resting cognitive and blood pressure tests may fail to detect short-term cognitive decline related to postural changes or real-world activities, leading to under-recognition of orthostatic hypotension’s cognitive impact. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 3 hours
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - About 3 hours
Participants undergo cognitive testing while lying down and upright on a tilt table, wearing devices to continuously monitor blood pressure and brain oxygen levels.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Katherine Longardner, Ece Bayram, Irene Litvan
https://pubmed.ncbi.nlm.nih.gov/32982926/David E Riley, Alberto J Espay
https://pubmed.ncbi.nlm.nih.gov/29456869/R Poda, P Guaraldi, L Solieri...
https://pubmed.ncbi.nlm.nih.gov/21894556/Jose-Alberto Palma, Juan Carlos Gomez-Esteban, Lucy Norcliffe-Kaufmann...
https://pubmed.ncbi.nlm.nih.gov/25678194/Horacio Kaufmann, Richard Malamut, Lucy Norcliffe-Kaufmann...
https://pubmed.ncbi.nlm.nih.gov/22045363/Ronald B Postuma, Daniela Berg, Matthew Stern...
https://pubmed.ncbi.nlm.nih.gov/26474316/Claire McDonald, Julia L Newton, David J Burn
https://pubmed.ncbi.nlm.nih.gov/27091624/Christopher G Goetz, Barbara C Tilley, Stephanie R Shaftman...
https://pubmed.ncbi.nlm.nih.gov/19025984/Michela Sforza, Francesca Assogna, Domiziana Rinaldi...
https://pubmed.ncbi.nlm.nih.gov/29627942/Christopher H Gibbons, Peter Schmidt, Italo Biaggioni...
https://pubmed.ncbi.nlm.nih.gov/28050656/University of California, San Diego
Lead Sponsor
Beth Israel Deaconess Medical Center
Collaborating Sponsor